Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001157523-22-000526
Filing Date
2022-05-02
Accepted
2022-05-02 16:16:07
Documents
2
Period of Report
2022-05-02

Document Format Files

Seq Description Document Type Size
1 NANOBIOTIX S.A. 6-K a52704637.htm 6-K 7926
2 EXHIBIT 99.1 a52704637ex99_1.htm EX-99.1 11830
  Complete submission text file 0001157523-22-000526.txt   20713
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39777 | Film No.: 22882159
SIC: 2834 Pharmaceutical Preparations